International scientific community gathers in Valencia for the 9th ESWI Conference on Influenza, COVID-19, and RSV
Since it was established 30 years ago, the European Scientific Working Group on Influenza and other Acute Respiratory Viruses (ESWI) is hosting the 9TH ESWI Influenza Conference
Co-evolution of immunity and seasonal influenza viruses
Seasonal influenza viruses cause recurring global epidemics by continually evolving to escape host immunity. The viral constraints and host immune responses that limit and drive the evolution of these viruses are increasingly well understood.
Cotransfer of antigen and contextual information harmonizes peripheral and lymph node conventional dendritic cell activation
T cell responses against infections and cancer are directed by conventional dendritic cells (cDCs) in lymph nodes distant from the site of challenge.
Policy & Recommendations
News
Eurostat presents Influenza statistics from 2019, 2020 and 2021
This article presents an overview of European Union (EU) statistics related to influenza.
|
ESWI Airborne: Burden of Disease
Burden of disease - A focus on acute respiratory viruses in older adults
Why should older adults be particularly careful of acute respiratory viruses? What are risk factors for adverse outcomes? Why is RSV typically under-diagnosed in adults compared with flu and what are some of the long-term impacts?
The impact of the SARS-CoV-2 pandemic on global influenza surveillance: Insights from 18 National Influenza Centers based on a survey conducted between November 2021 and March 2022
National Influenza Centers have played a crucial role in the surveillance of SARS-CoV-2. The FluCov project, covering 22 countries, was initiated to monitor the impact of the SARS-CoV-2 pandemic on influenza activity.
Influenza Vaccines: What Does the mRNA Platform Have to Offer?
Are you up to date about current developments in influenza vaccines with the messenger RNA (mRNA) platform?
Reaching for New Heights: Breaking Down Influenza Trends and Prevention Efforts
Did you know that in female children, influenza pneumonia is the second most common cause of death?
How mRNA technology is improving the flu Shot: The Big Take podcast by Bloomberg
It’s estimated that half a million or more people around the world die of influenza each year. And many of these deaths could be prevented with a highly effective, widely used flu shot.
|
ESWI Airborne: Meet the Members
Celebrating ESWI 30 years!
Who would have taken virus isolation for granted 30 years ago? How and why did ESWI transform from a pure virology-based network to one encompassing a public health perspective?
Evidence for an aquatic origin of influenza virus and the order Articulavirales
The emergence of novel disease-causing viruses in mammals is part of the long evolutionary history of viruses. Tracing these evolutionary histories contextualises virus spill over events and may help to elucidate how and why they occur.
Influenza vaccination in patients affected by diabetes
The effects of vaccination appear to be more effective when using higher-dose and quadrivalent vaccines, although subgroup-specific separate analyses in patients with diabetes are lacking.